10 Reasons We Like DaVita Dialysis as the Tenant of our DST 1031 Exchange Investments

  1. DaVita is a Fortune 500® company publicly traded on the NYSE as DVA3
  2. DaVita Kidney Care is a leading provider of kidney care in the United States, with clinical outcomes that were the best or among the best in the United States in almost every category in 20171
  3. DaVita has a market capitalization of $12.8 billion as of August 6, 20184
  4. DaVita has 70,800 full time employees2
  5. DaVita had annual revenue of $11.11 billion in 20174
  6. DaVita VillageHealth program continues to grow its commercial and government operations with more than 10 health plan and health system partnerships, 8 Medicare Advantage Special Needs Plans and 3 ESRD Seamless Care Organizations (ESCOs)1
  7. DaVita achieved savings of $75 million during the first performance year of their pilot program with ESCOs1
  8. As of June 30, 2017, DaVita Kidney Care provided dialysis services to a total of approximately 214,700 patients at 2,662 outpatient dialysis centers, of which 2,445 centers were located in the United States and 217 centers were located in 11 countries outside of the United States.3
  9. DaVita’s leadership development initiatives and social responsibility efforts have been recognized by Fortune Magazine, Modern Healthcare, Newsweek, and World Blu2
  10. Legendary investor Warren Buffett’s Berkshire Hathaway Inc reported a 22.1% stake in DaVita as of May 3, 20185

References:

  1. “Davita’s 2017 Annual Report” https://investors.davita.com/financial-information/financial-reports
  2. https://www.davita.com/about
  3. https://investors.davita.com/
  4. https://finance.yahoo.com/quote/DVA/key-statistics?p=DVA
  5. https://fintel.io/soh/us/dva/berkshire-hathaway